Document Detail

In vitro and in vivo studies disclosed the depigmenting effects of gallic acid: A novel skin lightning agent for hyperpigmentary skin diseases.
MedLine Citation:
PMID:  23322673     Owner:  NLM     Status:  Publisher    
Gallic acid (GA) is a phenolic compound, which has been reported to suppress melanogenesis in melanoma cells. However, the molecular mechanism underlying this inhibitory effect was poorly understood. In this article, we revealed that GA down-regulated melanogenic regulatory genes including tyrosinase, tyrosinase related protein-1 (TRP-1), and dopachrome tatamerase (Dct) expression at transcriptional and translational level. In addition, GA effectively suppressed the microphthalmia-associated transcription factor (MITF) expression by down-regulating the cAMP-mediated PKA/CREB signaling cascades. To delineate the inhibition of MITF by GA, the activation of extracellular signal-regulated protein kinase (ERK) and AKT was investigated. GA caused significant increase of ERK and AKT phosphorylation, while ERK (PD98059) or AKT (LY294002) inhibitor prevents their phosphorylation and increased melanin biosynthesis. In addition, pre-treatment of MITF-siRNA significantly reduced melanin production from 100 to 40%, and even decreased into 10% by combination treatment with GA. Furthermore, UVB-induced hyperpigmentation in the mice skin was significantly rescued by topical application of GA for 4 weeks. Immunohistochemical analyses also confirmed that GA significantly inhibited melanin production followed by the down-regulation of MITF, tyrosinase and their regulatory proteins. In addition, when compared with control zebrafish, GA caused a remarkable inhibition on the endogenous pigmentation in the zebrafish. Results presented in this study strongly suggest that GA is an effective de-pigmenting or skin lightening cosmetics for topical application. © 2013 BioFactors, 2013.
K J Senthil Kumar; M Gokila Vani; Sheng-Yang Wang; Jiunn-Wang Liao; Li-Sung Hsu; Hsin-Ling Yang; You-Cheng Hseu
Related Documents :
21986503 - Midgestation maternal serum 25-hydroxyvitamin d level and soluble fms-like tyrosine kin...
14718543 - P38mapk acts in the bmp7-dependent stimulatory pathway during epithelial cell morphogen...
9726973 - Stress-activated protein kinase/jun n-terminal kinase is required for interleukin (il)-...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-16
Journal Detail:
Title:  BioFactors (Oxford, England)     Volume:  -     ISSN:  1872-8081     ISO Abbreviation:  Biofactors     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807441     Medline TA:  Biofactors     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 International Union of Biochemistry and Molecular Biology, Inc.
Department of Cosmeceutics, College of Pharmacy, China Medical University, Taichung, Taiwan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis.
Next Document:  Quantitative near infrared spectroscopic analysis of Q-Switched Nd:YAG treatment of generalized argy...